(FY)Jun 30, 2023 | (FY)Jun 30, 2022 | |
---|---|---|
Operating cash flow (direct method) | ||
Cash income from operating activities | ||
Cash paid | -151.10%-656.88K | -261.61K |
Payments to suppliers for goods and services | -151.10%-656.88K | ---261.61K |
Direct interest received | 803,090.91%88.35K | --11 |
Operating cash flow | -117.33%-568.53K | ---261.6K |
Investing cash flow | ||
Cash flow from continuing investing activities | -3,908.13%-1.02M | -25.41K |
Capital expenditure reported | -3,306.09%-865.56K | ---25.41K |
Net PPE purchase and sale | ---152.99K | ---- |
Cash from discontinued investing activities | ||
Investing cash flow | -3,908.13%-1.02M | ---25.41K |
Financing cash flow | ||
Cash flow from continuing financing activities | -105.40%-265.38K | 4.92M |
Net common stock issuance | -105.40%-265.38K | --4.92M |
Cash from discontinued financing activities | ||
Financing cash flow | -105.40%-265.38K | --4.92M |
Net cash flow | ||
Beginning cash position | --4.63M | ---- |
Current changes in cash | -140.01%-1.85M | --4.63M |
End cash Position | -40.01%2.78M | --4.63M |
Free cash from | -452.97%-1.59M | ---287.01K |
Accounting Standards | US-GAAP | US-GAAP |
No Data